global
burden
interpandem
influenza
high
estim
affect
billion
peopl
annual
million
sever
case
requir
hospit
intens
care
treatment
result
approxim
million
death
worryingli
drugresist
influenza
strain
emerg
rapid
rate
sever
hamper
abil
healthcar
system
contain
influenza
outbreak
therefor
altern
strategi
need
sever
influenza
infect
season
pandem
influenza
outbreak
normal
human
airway
epithelium
pseudostratifi
layer
ciliat
noncili
columnar
cell
goblet
cell
club
cell
basal
cell
airway
epithelium
protect
airway
infect
via
effici
mucociliari
clearanc
mcc
product
inflammatori
mediat
chemokin
virus
recruit
immun
cell
influenza
viru
breach
defens
human
airway
epithelium
caus
myriad
innat
respons
infect
host
respons
viral
invas
among
chang
critic
factor
determin
diseas
sever
may
lead
develop
diagnost
prognost
predict
marker
antiinfluenza
therapi
howev
studi
hitherto
perform
relev
model
human
model
influenza
feasibl
due
potenti
sever
infect
therefor
mechanist
studi
viralinduc
airway
chang
use
relev
model
lead
better
understand
develop
sever
complic
addit
need
greater
clariti
differ
immun
respons
view
rise
preval
chronic
diseas
diabet
mellitu
asthma
patient
disord
especi
suscept
sever
influenza
complic
compar
healthi
subject
thu
establish
baselin
respons
influenza
infect
healthi
tissu
benefici
facilit
futur
compar
studi
better
manag
influenza
patient
comorbid
although
studi
host
respons
influenza
infect
new
current
vitro
cell
line
accur
repres
human
airway
infect
due
lack
key
mucociliari
featur
henc
previous
develop
interfac
ali
human
airway
epitheli
cell
cultur
abl
sustain
influenza
infect
also
compar
transcriptom
respons
infect
human
nasal
epitheli
cell
hnec
vitro
vivo
influenza
infect
transcriptom
studi
comparison
reveal
peak
respons
influenza
differenti
transcriptom
signatur
hnec
highli
similar
signatur
influenza
infect
model
interestingli
compar
homogen
cell
line
test
heterogen
hnec
model
exhibit
compar
respons
clinic
influenza
studi
indic
respons
initi
nasal
epithelium
therefor
studi
aim
util
hnec
model
physiolog
relev
vitro
model
clarifi
nasal
epitheli
respons
influenza
infect
would
facilit
identif
key
host
factor
signific
futur
studi
establish
host
factor
significantli
alter
nasal
epithelium
refer
earli
innat
respons
influenza
dynam
express
gene
need
clearli
elucid
mani
studi
util
microarray
analysi
identifi
host
respons
influenza
limit
microarray
inabl
determin
full
extent
gene
chang
due
hybridizationbas
protocol
aim
studi
util
rna
sequenc
rnaseq
technolog
reveal
hnec
respons
multipl
individu
influenza
infect
also
identifi
gene
high
magnitud
chang
serv
potenti
refer
marker
innat
respons
influenza
infect
given
rnaseq
function
read
virtual
rna
present
sampl
test
also
discern
magnitud
rna
chang
mark
canon
respons
addit
rnaseq
constrain
probe
usag
microarray
therefor
reliabl
detect
novel
interact
influenza
infect
hnec
henc
rnaseq
analysi
augment
transcriptom
data
establish
previous
microarray
analysi
augment
baselin
appli
futur
clinic
studi
practic
influenza
infect
especi
comparison
patient
underli
comorbid
may
affect
sever
diseas
approv
conduct
studi
obtain
nation
healthcar
group
domainspecif
board
singapor
dsrb
ref
institut
review
board
nation
univers
singapor
irb
ref
written
consent
obtain
donor
prior
collect
tissu
biopsi
time
collect
subject
free
symptom
urti
medic
background
subject
summar
intabl
hnespc
isol
enrich
tissu
biopsi
accord
previous
standard
protocol
normal
hnespc
baselin
state
differenti
hnec
resembl
healthi
tissu
pass
qualiti
control
check
differenti
follow
enrich
hnespc
expand
subject
ali
cultur
transwel
vitro
differenti
accord
previou
protocol
well
briefli
primari
cell
subject
isol
select
hnespc
enrich
expand
dulbecco
modifi
eagl
medium
nutrient
mixtur
gibcoinvitrogen
carlsbad
ca
usa
contain
ngml
human
epitheli
growth
factor
egf
gibcoinvitrogen
carlsbad
ca
usa
insulin
sigma
st
loui
mo
usa
nm
cholera
toxin
sigma
st
loui
mo
usa
hydrocortison
sigma
st
loui
mo
usa
nmml
sigma
st
loui
mo
usa
supplement
gibcoinvitrogen
iuml
antibioticantimycot
gibcoinvitrogen
carlsbad
ca
usa
expand
hnespc
transfer
onto
transwel
insert
corn
corn
ny
usa
confluent
growth
medium
discard
medium
induc
supplement
stemcel
technolog
inc
vancouv
canada
ad
basal
chamber
establish
ali
condit
cell
cultur
ali
cultur
week
media
chang
everi
day
week
differenti
hnec
total
seven
donor
subject
influenza
viru
infect
influenza
strain
use
studi
subtyp
atcc
manassa
va
usa
viru
propag
use
embryon
egg
cultur
use
infect
hnec
prior
infect
fulli
differenti
hnec
wash
dpb
infect
influenza
viru
multipl
infect
moi
incub
h
h
incub
viral
inoculum
remov
hnec
incub
back
control
hnec
harvest
apic
wash
rna
prior
infect
h
postinfect
hpi
infect
hnec
harvest
apic
wash
rna
follow
hpi
incub
infect
time
point
dpb
ad
incub
apic
chamber
min
recov
progeni
virus
apic
wash
plaqu
assay
viral
quantif
perform
use
overnight
mdck
cultur
atcc
manassa
va
usa
confluenc
plate
mdck
cell
incub
serial
dilut
viru
apic
wash
h
plate
rock
everi
min
ensur
equal
viral
distribut
incub
inocula
remov
replac
ml
avicel
fmc
biopolym
philadelphia
pa
usa
overlay
incub
h
incub
avicel
overlay
remov
cell
fix
formaldehyd
pb
h
formaldehyd
remov
cell
wash
pb
prior
stain
crystal
violet
min
wash
stain
away
plaqueform
unit
pfu
calcul
follow
number
plaqu
dilut
factor
number
pfu
per
time
point
collect
apic
wash
hnec
lyse
use
rna
lysi
buffer
total
rna
extract
lysat
use
mirvana
mirna
isol
kit
life
technolog
grand
island
ny
usa
extract
total
rna
first
subject
nanodrop
analysi
first
ensur
rna
qualiti
submit
rnaseq
analysi
ng
remain
rna
subject
cdna
synthesi
use
maxima
firststrand
cdna
synthesi
kit
thermoscientif
pittsburgh
pa
usa
qpcr
analysi
perform
evalu
transcript
level
host
respons
gene
select
base
previou
microarray
analysi
use
predesign
primer
sigma
aldrich
qpcr
reaction
perform
duplic
use
gotaqqpcr
master
mix
kit
promega
san
lui
obispo
ca
usa
rel
gene
express
calcul
use
compar
method
normal
housekeep
gene
rel
gene
express
level
present
median
valu
interquartil
rang
statist
signific
determin
use
wilcoxon
signedrank
test
human
rna
analyz
agil
bioanalyz
agil
santa
clara
ca
usa
perkin
elmer
labchip
gx
system
perkin
elmer
waltham
usa
qualiti
assess
rna
integr
number
rin
rna
qualiti
score
rang
median
cdna
librari
prepar
use
ng
total
rna
dilut
ercc
rna
spike
control
thermo
fisher
scientif
waltham
usa
use
smartseq
protocol
except
follow
modif
use
tso
use
pg
cdna
reaction
illumina
nextera
xt
kit
illumina
san
diego
ca
usa
length
distribut
cdna
librari
monitor
use
dna
high
sensit
reagent
kit
perkin
elmer
labchip
gx
system
perkin
elmer
waltham
usa
sixteen
sampl
subject
index
pe
sequenc
run
cycl
illumina
hiseq
sampleslan
sampl
index
pe
sequenc
run
cycl
illumina
hiseq
sampleslan
fastq
file
map
human
genom
build
use
star
gene
count
comput
use
featurecount
part
subread
packag
use
annot
gencod
version
differenti
gene
express
analysi
perform
use
edger
pair
fashion
r
version
multipl
test
correct
done
use
method
benjamini
hochberg
pvalu
fals
discoveri
rate
fdr
less
deem
signific
geneset
enrich
analysi
use
data
gene
ontolog
go
perform
use
bioconductor
packag
topgo
analysi
use
reactom
pathway
perform
use
vioconductor
packag
reactomepa
analys
run
r
version
use
multipl
testingcorrect
signific
differentiallyexpress
gene
luminex
assay
perform
apic
supernat
collect
uninfect
control
infect
hnec
hpi
use
multiplex
immunoassay
human
cytokinechemokin
panel
merck
cat
kenilworth
nj
usa
panel
includ
detect
human
egf
ligand
fractalkin
gcsf
gmcsf
gro
mdc
pdgfabbb
rant
vegf
pdgfaa
sampl
standard
incub
fluorescentcod
magnet
bead
precoat
respect
captur
antibodi
overnight
incub
plate
wash
twice
biotinyl
detect
antibodi
incub
complex
h
streptavidinp
ad
incub
anoth
min
plate
wash
twice
bead
resuspend
sheath
fluid
acquir
luminex
use
luminex
acquisit
softwar
data
analysi
done
bioplex
biorad
standard
curv
gener
logist
algorithm
report
valu
mfi
concentr
data
result
express
mean
fold
chang
compar
uninfect
control
pvalu
fdr
less
consid
signific
prior
analysi
respons
seven
hnec
donor
follow
influenza
infect
plot
princip
compon
analysi
pca
plot
pca
plot
indic
degre
variabl
respons
donor
time
point
figur
nonetheless
respons
cluster
tightli
enough
follow
infect
signifi
consist
infect
transcriptom
observ
previou
studi
signific
gene
express
chang
fdr
infect
hnec
detect
earli
hpi
increas
hpi
tabl
figur
also
number
gene
decreas
linear
fashion
fold
chang
express
increas
seen
fold
chang
gene
indic
figur
significantli
alter
gene
remain
hpi
upregul
gene
downregul
gene
major
upregul
gene
antivir
sensor
earli
respons
gene
ifn
ifit
ifi
interestingli
enough
interferon
lambda
gene
ifnl
earliest
respons
interferon
infect
hnec
oppos
interferon
alpha
beta
hpi
later
time
point
number
gene
express
chang
increas
substanti
upregul
gene
downregul
gene
hpi
respect
augment
express
antivir
effector
inflammatori
gene
time
point
ifnl
remain
interferon
gene
highest
express
time
point
mark
elev
cytokin
also
observ
consid
downregul
gene
prolif
transcriptom
function
appear
suppress
diminish
express
gene
fosb
gene
associ
metabol
cell
cycl
dna
repair
suppress
follow
infect
hpi
tabl
list
complet
set
signific
gene
express
chang
arrang
accord
fold
chang
addit
also
verifi
gene
show
major
express
chang
rnaseq
gener
concur
rtqpcr
analys
gene
test
qpcr
hpi
show
direct
chang
express
observ
rnaseq
henc
seven
gene
show
pvalu
one
gene
pvalu
ctgf
two
gene
statist
signific
tgfa
figur
compar
transcriptom
alter
hnec
time
follow
influenza
infect
number
gene
express
chang
mirror
viral
titer
chang
peak
hpi
consist
donor
figur
approxim
two
third
gene
hpi
overlap
time
point
one
third
gene
hpi
overlap
figur
overlap
gene
display
similar
direct
consist
signific
time
point
addit
congruent
consist
viral
titer
gene
express
chang
hpi
also
note
consist
alter
express
gene
across
donor
highlight
figur
portray
heatmap
top
gene
smallest
pvalu
togeth
direct
magnitud
chang
base
analys
propos
hpi
repres
optim
time
point
subsequ
pathway
analysi
ascertain
influenzaspecif
pathway
chang
subject
signific
gene
chang
gene
set
enrich
use
go
reactom
databas
time
point
hpi
signific
adjust
pvalu
go
biolog
process
tabl
signific
adjust
pvalu
reactom
pathway
tabl
respect
earli
time
hpi
interferonmedi
antivir
respons
elev
expect
hpi
pathway
appear
stabil
consist
go
reactom
analys
despit
display
gene
express
chang
time
point
respons
influenza
viru
skew
toward
type
immun
predomin
go
analysi
expect
interferonmedi
function
epithelium
valid
authent
model
found
enrich
type
interferon
go
rigi
reactom
pathway
upregul
nearli
signific
gene
member
data
shown
besid
interferon
antivir
pathway
identifi
sever
function
interest
initi
nasal
epithelium
may
contribut
patholog
pathogenesi
influenza
hpi
go
pathway
enrich
analysi
reveal
nasal
epithelium
activ
involv
initi
signal
despit
directli
produc
also
observ
enrich
function
apoptosi
necroptosi
immun
evas
pathway
may
lead
complic
event
smooth
muscl
prolifer
respons
fatti
acid
tabl
reactom
pathway
analysi
select
pathway
enrich
signific
gene
present
enrich
pathway
gener
agreement
go
analysi
tabl
addit
signal
apoptosi
also
reveal
chang
epithelialiniti
b
cell
receptor
signal
amino
acid
metabol
follow
influenza
infect
noteworthi
pathway
initi
epitheli
level
without
particip
immun
cell
thu
highlight
relev
gene
interest
futur
studi
given
rnaseq
analysi
facilit
accur
express
chang
follow
infect
compar
hybrid
technolog
microarray
conduct
analysi
level
gene
express
chang
enabl
stringent
accur
transcriptom
analys
futur
studi
compar
result
previou
studi
identifi
influenzaspecif
signatur
verifi
gene
express
infect
nasal
epithelium
later
hpi
hpi
furthermor
hpi
one
gene
signatur
exhibit
elev
express
chang
compar
uninfect
control
hnec
tabl
appli
higher
fold
chang
cutoff
number
signific
gene
decreas
approxim
figur
also
congruent
linear
associ
observ
earlier
therefor
futur
studi
earli
transcript
alter
could
consid
adopt
chang
express
stringent
threshold
may
feasibl
especi
larg
transcriptom
studi
yield
larg
number
data
point
addit
compar
previou
microarray
studi
similar
hnec
model
rnaseq
microarray
share
high
degre
overlap
one
third
half
total
gene
rnaseq
microarray
overlap
respect
figur
overlap
gener
observ
gene
highli
alter
express
chang
similar
magnitud
rnaseq
microarray
tabl
compar
influenza
signatur
gene
rnaseq
reveal
consist
increas
magnitud
ie
hpi
magnitud
gene
chang
gener
higher
microarray
tabl
addit
rnaseq
also
abl
detect
novel
gene
express
chang
high
magnitud
gener
higher
found
microarray
gene
versu
gene
elev
express
greater
gene
alter
higher
magnitud
threshold
henc
rnaseqbas
transcriptom
analysi
may
augment
transcriptom
find
identifi
novel
gene
respons
influenza
futur
deriv
transcriptom
rnaseq
investig
whether
chang
express
gene
result
alter
secretori
cytokin
chemokin
earli
infect
hnec
initi
detect
signific
reduct
multipl
cytokin
hpi
except
increas
figur
may
reflect
initi
immun
suppress
influenza
infect
howev
hpi
less
signific
chang
observ
ie
increas
tnfa
decreas
mdc
pdgfaa
note
hpi
follow
increas
tgfa
decreas
pdgfaa
seen
hpi
analysi
highlight
chang
tgfa
pdgfaa
signific
earli
respons
secretori
cytokineschemokin
follow
influenza
infect
studi
identifi
epitheliuminiti
host
respons
found
involv
innat
adapt
respons
find
signific
focu
primari
point
contact
nasal
epithelium
studi
earli
host
respons
identifi
host
factor
util
diagnost
therapeut
purpos
addit
studi
also
show
import
refer
databas
use
relev
human
model
like
hnec
model
contain
mucociliari
compon
airway
order
provid
close
repres
host
respons
exist
high
number
microarray
studi
show
host
respons
use
similar
hnec
model
small
number
equival
rnaseq
studi
compar
microarray
rnaseq
analysi
provid
comprehens
pictur
transcriptom
landscap
limit
hybrid
librari
variant
concentr
henc
order
deriv
accur
magnitud
gene
express
chang
perform
rnaseq
analysi
infect
use
hnec
model
influenza
viru
select
given
major
circul
subtyp
long
period
time
addit
rel
lower
efficaci
vaccin
subtyp
prompt
us
studi
interact
primari
host
target
elucid
immun
respons
associ
adapt
immun
model
previous
evalu
highli
clinicallyrelev
model
facilit
control
infect
nasal
cell
multipl
individu
addit
also
previous
microarray
nasal
epithelium
respons
initi
host
respons
follow
influenza
infect
render
hnec
serv
valuabl
tool
analyz
transcriptom
differ
individu
infect
condit
ensur
consist
relev
respons
human
magnitud
gene
express
chang
consid
sever
interest
find
emerg
firstli
infect
hnec
observ
strong
activ
antivir
gene
earli
inflammatori
gene
lead
type
immun
respons
larg
number
gene
express
chang
magnitud
differ
fold
chang
gene
highmagnitud
express
chang
verifi
qpcr
statist
signific
congruent
rnaseq
analysi
secondli
despit
absenc
immun
cell
infect
hnec
abl
gener
strong
type
respons
may
like
aid
recruit
cytotox
cell
clear
infect
cell
thirdli
earli
respons
hnec
gene
repres
type
iii
interferon
strongli
induc
frequent
observ
type
interferon
type
ii
interferon
produc
hnec
agreement
previou
studi
induct
type
iii
interferon
may
reflect
import
event
within
hnec
initi
respond
infect
may
benefici
antivir
respons
moreov
also
observ
notabl
suppress
express
certain
gene
follow
influenza
infect
includ
suppress
prolifer
dna
repair
gene
may
contribut
patholog
pathogenesi
influenza
final
rnaseq
also
unravel
express
chang
certain
newlydiscov
gene
respons
influenza
infect
upper
airway
cell
gene
baff
recent
implic
influenza
pathogenesi
mucos
defens
therebi
signifi
role
nasal
epithelium
influenza
infect
furthermor
rnaseq
identifi
alter
express
gene
previous
detect
influenza
transcriptom
find
henc
reiter
valu
rnaseq
enhanc
data
influenza
transcriptom
refer
futur
studi
via
pathway
enrich
analysi
identifi
known
antivir
pathway
valid
hnec
respons
influenza
addit
also
document
potenti
pathway
initi
nasal
epithelium
may
contribut
influenza
pathogenesi
repres
gene
express
chang
list
tabl
tabl
analys
use
literatureinf
go
reactom
databas
demonstr
nasal
epithelium
play
role
main
antivir
signal
ie
respons
despit
direct
produc
pathway
enrich
indic
hnec
may
serv
import
regul
type
ii
interferon
even
though
effect
vital
robust
clearanc
influenza
virus
report
unregul
contributor
inflammatori
damag
therefor
overproduct
respons
factor
may
contribut
inflammatori
damag
epithelium
henc
product
factor
hnec
also
crucial
ensur
appropri
regul
express
influenza
respons
gene
modul
inflamm
minim
damag
primari
contact
influenza
viru
nasal
epithelium
may
subsequ
lead
damag
airway
epithelium
well
appar
clear
enrich
pathway
apoptosi
mitochondri
apoptot
process
necroptosi
contribut
cell
death
mechan
barrier
loss
infect
gene
fa
suggest
activ
apoptot
cell
death
destroy
cell
epitheli
barrier
may
also
serv
propag
viru
perpetu
damag
furthermor
viru
infect
aberr
regul
apoptosi
may
also
lead
injuri
epithelium
surround
tissu
hand
necroptosi
pathway
also
observ
enrich
influenzainfect
hnec
compar
apoptosi
studi
necroptosi
influenza
infect
rel
new
contradict
find
studi
appear
gener
contradictori
result
whether
necroptosi
protect
detriment
influenza
infect
henc
increas
express
infect
hnec
warrant
investig
role
influenzainduc
damag
addit
also
note
enrich
bcell
signal
pathway
infect
hnec
may
vital
bcell
respons
adapt
immun
respons
note
gene
enrich
bcell
pathway
relat
antigen
recognit
proteasom
subunit
etc
bcell
receptorassoci
gene
howev
chang
express
certain
growth
factor
includ
ereg
fgf
follow
influenza
infect
may
lead
complic
involv
airway
remodel
recruit
effect
growth
factor
confirm
enrich
pathway
relat
prolifer
smooth
muscl
cell
also
induc
infect
chang
airway
smooth
muscl
cell
usual
implic
airway
remodel
may
also
contribut
postinfluenza
complic
henc
gene
found
studi
may
crucial
elucid
nasaliniti
respons
may
contribut
patholog
pathogenesi
influenza
infect
airway
final
anoth
interest
pathway
may
contribut
epitheli
damag
neg
regul
innat
immun
respons
gene
may
serv
provir
factor
aid
immun
evas
exampl
adar
provir
factor
work
synergi
influenza
enhanc
viral
replic
neg
regul
tolllik
receptor
signal
upregul
influenzainfect
hnec
neg
regul
signal
pathway
involv
regul
liver
inflamm
express
appear
exert
antivir
effect
influenza
viru
nmi
bind
influenza
viru
inhibit
interferon
signal
therefor
aberr
express
gene
signal
pathway
may
directli
contribut
immun
evas
influenza
culmin
viral
propag
increas
epitheli
damag
summar
identifi
pathway
list
tabl
tabl
allud
immun
evas
neg
regul
innat
immun
respons
antigen
process
metabol
amino
acid
deriv
immunomodul
interferon
gamma
signal
b
cell
receptor
signal
respons
fatti
acid
may
contribut
sever
influenza
evid
direct
pathway
enrich
potenti
influenza
evas
strategi
andor
immunomodul
accompani
transcriptom
chang
gene
pathway
may
analyz
immunomodulatori
activ
whether
express
benefici
viru
immun
evas
host
prevent
cytokin
storm
addit
infect
hnec
also
reveal
modifi
respons
associ
fatti
acid
mani
lipid
signal
molecul
leukotrien
mediat
antivir
respons
subsequ
inflamm
airway
modifi
respons
may
also
determin
afford
airway
sever
airway
inflamm
damag
addit
modif
may
also
affect
lower
airway
respons
inflammatori
mediat
henc
chang
pathway
may
also
suggest
potenti
mechanist
link
pathogenesi
viralinduc
exacerb
chronic
inflammatori
diseas
lastli
also
note
enrich
pathway
relat
amino
acid
metabol
import
antigen
process
proteasom
degrad
foreign
protein
chang
gene
hnec
target
site
influenza
infect
may
determin
effect
antivir
respons
mount
may
therefor
influenza
diseas
sever
addit
also
compar
rnaseq
analysi
previous
report
influenzaspecif
signatur
order
improv
futur
transcriptom
analysi
vitro
transcriptom
analysi
yield
larg
number
differentiallyexpress
gene
would
requir
addit
criteria
identifi
function
signific
gene
mean
comparison
discov
almost
influenzaspecif
signatur
exhibit
differ
express
henc
propos
appli
fold
chang
threshold
futur
vitro
transcriptom
system
analys
order
increas
stringenc
detect
function
signific
gene
chang
final
observ
unlik
transcriptom
notabl
fewer
cytokin
readili
secret
acut
phase
infect
express
cytokin
reduc
hpi
except
interestingli
implic
influenzainduc
acut
lung
injuri
even
fewer
cytokin
show
alter
express
later
time
point
among
tgfa
pdgfaa
significantli
alter
hpi
may
signific
marker
detect
secret
influenzainfect
mucos
surfac
may
influenc
sever
influenza
wellestablish
respons
gene
serv
use
marker
respons
influenza
tgfa
repres
import
factor
involv
secret
respons
influenza
may
determin
earli
appropri
innat
respons
prevent
sever
diseas
hand
also
involv
pulmonari
fibrosi
ligand
epiderm
growth
factor
receptor
egfr
may
contribut
complic
lower
airway
pdgfaa
found
elev
cerebrospin
fluid
influenzaassoci
encephalopathi
consist
reduc
hnec
secretori
fluid
thu
warrant
investig
role
infect
nasal
mucosa
establish
refer
transcriptom
base
earli
respons
human
nasal
epithelium
model
serv
key
role
research
critic
host
factor
involv
influenza
primari
host
contact
viru
immun
respons
influenza
import
also
alter
nonimmun
function
metabol
cell
content
cell
cycl
may
contribut
diseas
sever
term
translat
potenti
model
system
identifi
gene
express
chang
signific
magnitud
pathway
impact
respons
influenza
sever
gene
may
repres
novel
target
futur
diagnost
therapeut
develop
control
condit
hnec
clinic
establish
baselin
normal
innat
immun
respons
nasal
epithelium
influenza
viral
infect
baselin
particularli
crucial
studi
chang
innat
immun
respons
influenza
especi
patient
underli
chronic
diseas
may
aberr
airway
respons
influenza
antivir
respons
may
differ
normal
subject
studi
thu
provid
basi
compar
differenti
respons
culmin
sever
infect
patient
comorbid
diabet
chronic
airway
inflammatori
diseas
compar
clinic
studi
potenti
enhanc
manag
influenza
viral
infect
patient
chronic
diseas
conclus
rnaseq
technolog
allow
us
accur
quantifi
magnitud
gene
express
chang
well
relev
enrich
pathway
influenza
viru
infect
hnec
serv
baselin
futur
clinic
studi
establish
baselin
control
condit
elucid
antivir
innat
respons
infect
nasal
epithelium
highlight
molecular
factor
abnorm
upper
airway
may
contribut
influenza
sever
furthermor
studi
also
culmin
identif
novel
gene
signatur
host
factor
may
har
futur
research
develop
influenza
diagnost
marker
therapeut
target
